nodes	percent_of_prediction	percent_of_DWPC	metapath
Palonosetron—CYP1A2—Carmustine—malignant glioma	0.452	0.57	CbGbCtD
Palonosetron—CYP3A4—Temozolomide—malignant glioma	0.342	0.431	CbGbCtD
Palonosetron—HTR3A—fourth ventricle—malignant glioma	0.0612	0.753	CbGeAlD
Palonosetron—HTR3A—brainstem—malignant glioma	0.0048	0.059	CbGeAlD
Palonosetron—HTR3A—telencephalon—malignant glioma	0.00426	0.0524	CbGeAlD
Palonosetron—Hyperbilirubinaemia—Temozolomide—malignant glioma	0.00298	0.0256	CcSEcCtD
Palonosetron—Hepatic enzyme increased—Temozolomide—malignant glioma	0.00286	0.0246	CcSEcCtD
Palonosetron—Injection site reaction—Carmustine—malignant glioma	0.00279	0.024	CcSEcCtD
Palonosetron—Respiratory failure—Temozolomide—malignant glioma	0.00276	0.0237	CcSEcCtD
Palonosetron—Influenza like illness—Temozolomide—malignant glioma	0.00263	0.0226	CcSEcCtD
Palonosetron—HTR3A—central nervous system—malignant glioma	0.00242	0.0298	CbGeAlD
Palonosetron—Hot flush—Temozolomide—malignant glioma	0.0021	0.0181	CcSEcCtD
Palonosetron—Menopausal symptoms—Temozolomide—malignant glioma	0.00208	0.0179	CcSEcCtD
Palonosetron—HTR3A—brain—malignant glioma	0.00192	0.0236	CbGeAlD
Palonosetron—Hypokalaemia—Carmustine—malignant glioma	0.00185	0.0159	CcSEcCtD
Palonosetron—Hypokalaemia—Temozolomide—malignant glioma	0.00179	0.0154	CcSEcCtD
Palonosetron—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00177	0.0152	CcSEcCtD
Palonosetron—CYP2D6—brainstem—malignant glioma	0.00176	0.0217	CbGeAlD
Palonosetron—Abdominal distension—Temozolomide—malignant glioma	0.00171	0.0147	CcSEcCtD
Palonosetron—Hyperglycaemia—Carmustine—malignant glioma	0.00159	0.0136	CcSEcCtD
Palonosetron—CYP2D6—telencephalon—malignant glioma	0.00156	0.0193	CbGeAlD
Palonosetron—Hyperglycaemia—Temozolomide—malignant glioma	0.00153	0.0132	CcSEcCtD
Palonosetron—Hepatobiliary disease—Temozolomide—malignant glioma	0.00143	0.0123	CcSEcCtD
Palonosetron—Sinusitis—Temozolomide—malignant glioma	0.00142	0.0122	CcSEcCtD
Palonosetron—Connective tissue disorder—Carmustine—malignant glioma	0.00138	0.0119	CcSEcCtD
Palonosetron—Urinary tract disorder—Temozolomide—malignant glioma	0.00134	0.0116	CcSEcCtD
Palonosetron—Connective tissue disorder—Temozolomide—malignant glioma	0.00134	0.0115	CcSEcCtD
Palonosetron—Urethral disorder—Temozolomide—malignant glioma	0.00133	0.0115	CcSEcCtD
Palonosetron—Eye disorder—Carmustine—malignant glioma	0.00132	0.0113	CcSEcCtD
Palonosetron—Eye disorder—Temozolomide—malignant glioma	0.00127	0.0109	CcSEcCtD
Palonosetron—Tinnitus—Temozolomide—malignant glioma	0.00127	0.0109	CcSEcCtD
Palonosetron—Cardiac disorder—Temozolomide—malignant glioma	0.00126	0.0109	CcSEcCtD
Palonosetron—Arrhythmia—Carmustine—malignant glioma	0.00126	0.0108	CcSEcCtD
Palonosetron—Alopecia—Carmustine—malignant glioma	0.00124	0.0107	CcSEcCtD
Palonosetron—Angiopathy—Temozolomide—malignant glioma	0.00123	0.0106	CcSEcCtD
Palonosetron—Mental disorder—Carmustine—malignant glioma	0.00123	0.0106	CcSEcCtD
Palonosetron—Immune system disorder—Temozolomide—malignant glioma	0.00123	0.0106	CcSEcCtD
Palonosetron—Mediastinal disorder—Temozolomide—malignant glioma	0.00123	0.0105	CcSEcCtD
Palonosetron—Erythema—Carmustine—malignant glioma	0.00123	0.0105	CcSEcCtD
Palonosetron—Malnutrition—Carmustine—malignant glioma	0.00123	0.0105	CcSEcCtD
Palonosetron—Chills—Temozolomide—malignant glioma	0.00122	0.0105	CcSEcCtD
Palonosetron—Alopecia—Temozolomide—malignant glioma	0.0012	0.0103	CcSEcCtD
Palonosetron—Mental disorder—Temozolomide—malignant glioma	0.00119	0.0103	CcSEcCtD
Palonosetron—Malnutrition—Temozolomide—malignant glioma	0.00118	0.0102	CcSEcCtD
Palonosetron—Erythema—Temozolomide—malignant glioma	0.00118	0.0102	CcSEcCtD
Palonosetron—Dysgeusia—Temozolomide—malignant glioma	0.00116	0.00998	CcSEcCtD
Palonosetron—Anaemia—Carmustine—malignant glioma	0.00113	0.00974	CcSEcCtD
Palonosetron—Anaemia—Temozolomide—malignant glioma	0.00109	0.00942	CcSEcCtD
Palonosetron—Convulsion—Carmustine—malignant glioma	0.00106	0.00913	CcSEcCtD
Palonosetron—Hypertension—Carmustine—malignant glioma	0.00106	0.0091	CcSEcCtD
Palonosetron—Myalgia—Carmustine—malignant glioma	0.00104	0.00897	CcSEcCtD
Palonosetron—Anxiety—Carmustine—malignant glioma	0.00104	0.00894	CcSEcCtD
Palonosetron—Convulsion—Temozolomide—malignant glioma	0.00103	0.00883	CcSEcCtD
Palonosetron—Hypertension—Temozolomide—malignant glioma	0.00102	0.0088	CcSEcCtD
Palonosetron—Arthralgia—Temozolomide—malignant glioma	0.00101	0.00867	CcSEcCtD
Palonosetron—Myalgia—Temozolomide—malignant glioma	0.00101	0.00867	CcSEcCtD
Palonosetron—Anxiety—Temozolomide—malignant glioma	0.001	0.00864	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.001	0.00861	CcSEcCtD
Palonosetron—Discomfort—Temozolomide—malignant glioma	0.000996	0.00857	CcSEcCtD
Palonosetron—Infection—Carmustine—malignant glioma	0.000993	0.00855	CcSEcCtD
Palonosetron—Dry mouth—Temozolomide—malignant glioma	0.000986	0.00848	CcSEcCtD
Palonosetron—Tachycardia—Carmustine—malignant glioma	0.000976	0.0084	CcSEcCtD
Palonosetron—Anaphylactic shock—Temozolomide—malignant glioma	0.000966	0.00831	CcSEcCtD
Palonosetron—Infection—Temozolomide—malignant glioma	0.00096	0.00826	CcSEcCtD
Palonosetron—Anorexia—Carmustine—malignant glioma	0.000953	0.0082	CcSEcCtD
Palonosetron—Nervous system disorder—Temozolomide—malignant glioma	0.000948	0.00815	CcSEcCtD
Palonosetron—Skin disorder—Temozolomide—malignant glioma	0.000939	0.00808	CcSEcCtD
Palonosetron—Hypotension—Carmustine—malignant glioma	0.000934	0.00804	CcSEcCtD
Palonosetron—Anorexia—Temozolomide—malignant glioma	0.000921	0.00793	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000911	0.00784	CcSEcCtD
Palonosetron—Insomnia—Carmustine—malignant glioma	0.000904	0.00778	CcSEcCtD
Palonosetron—CYP3A4—central nervous system—malignant glioma	0.000903	0.0111	CbGeAlD
Palonosetron—Paraesthesia—Carmustine—malignant glioma	0.000898	0.00773	CcSEcCtD
Palonosetron—Dyspnoea—Carmustine—malignant glioma	0.000891	0.00767	CcSEcCtD
Palonosetron—CYP2D6—central nervous system—malignant glioma	0.000889	0.0109	CbGeAlD
Palonosetron—Somnolence—Carmustine—malignant glioma	0.000889	0.00765	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00088	0.00758	CcSEcCtD
Palonosetron—Insomnia—Temozolomide—malignant glioma	0.000874	0.00752	CcSEcCtD
Palonosetron—Decreased appetite—Carmustine—malignant glioma	0.000869	0.00748	CcSEcCtD
Palonosetron—CYP2D6—cerebellum—malignant glioma	0.000869	0.0107	CbGeAlD
Palonosetron—Paraesthesia—Temozolomide—malignant glioma	0.000868	0.00747	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Carmustine—malignant glioma	0.000863	0.00743	CcSEcCtD
Palonosetron—Dyspnoea—Temozolomide—malignant glioma	0.000861	0.00741	CcSEcCtD
Palonosetron—Somnolence—Temozolomide—malignant glioma	0.000859	0.00739	CcSEcCtD
Palonosetron—Pain—Carmustine—malignant glioma	0.000855	0.00736	CcSEcCtD
Palonosetron—Constipation—Carmustine—malignant glioma	0.000855	0.00736	CcSEcCtD
Palonosetron—Dyspepsia—Temozolomide—malignant glioma	0.000851	0.00732	CcSEcCtD
Palonosetron—Decreased appetite—Temozolomide—malignant glioma	0.00084	0.00723	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000834	0.00718	CcSEcCtD
Palonosetron—Fatigue—Temozolomide—malignant glioma	0.000833	0.00717	CcSEcCtD
Palonosetron—Pain—Temozolomide—malignant glioma	0.000826	0.00711	CcSEcCtD
Palonosetron—Constipation—Temozolomide—malignant glioma	0.000826	0.00711	CcSEcCtD
Palonosetron—Gastrointestinal pain—Carmustine—malignant glioma	0.000818	0.00704	CcSEcCtD
Palonosetron—Abdominal pain—Carmustine—malignant glioma	0.00079	0.0068	CcSEcCtD
Palonosetron—Body temperature increased—Carmustine—malignant glioma	0.00079	0.0068	CcSEcCtD
Palonosetron—Gastrointestinal pain—Temozolomide—malignant glioma	0.00079	0.0068	CcSEcCtD
Palonosetron—Abdominal pain—Temozolomide—malignant glioma	0.000764	0.00657	CcSEcCtD
Palonosetron—Body temperature increased—Temozolomide—malignant glioma	0.000764	0.00657	CcSEcCtD
Palonosetron—Hypersensitivity—Carmustine—malignant glioma	0.000737	0.00634	CcSEcCtD
Palonosetron—Asthenia—Carmustine—malignant glioma	0.000717	0.00617	CcSEcCtD
Palonosetron—Hypersensitivity—Temozolomide—malignant glioma	0.000712	0.00613	CcSEcCtD
Palonosetron—CYP2D6—brain—malignant glioma	0.000706	0.00869	CbGeAlD
Palonosetron—Asthenia—Temozolomide—malignant glioma	0.000693	0.00597	CcSEcCtD
Palonosetron—Diarrhoea—Carmustine—malignant glioma	0.000684	0.00589	CcSEcCtD
Palonosetron—Pruritus—Temozolomide—malignant glioma	0.000684	0.00588	CcSEcCtD
Palonosetron—Dizziness—Carmustine—malignant glioma	0.000661	0.00569	CcSEcCtD
Palonosetron—Diarrhoea—Temozolomide—malignant glioma	0.000661	0.00569	CcSEcCtD
Palonosetron—Dizziness—Temozolomide—malignant glioma	0.000639	0.0055	CcSEcCtD
Palonosetron—Vomiting—Carmustine—malignant glioma	0.000636	0.00547	CcSEcCtD
Palonosetron—Rash—Carmustine—malignant glioma	0.00063	0.00542	CcSEcCtD
Palonosetron—Dermatitis—Carmustine—malignant glioma	0.00063	0.00542	CcSEcCtD
Palonosetron—Headache—Carmustine—malignant glioma	0.000626	0.00539	CcSEcCtD
Palonosetron—Vomiting—Temozolomide—malignant glioma	0.000614	0.00529	CcSEcCtD
Palonosetron—Rash—Temozolomide—malignant glioma	0.000609	0.00524	CcSEcCtD
Palonosetron—Dermatitis—Temozolomide—malignant glioma	0.000609	0.00524	CcSEcCtD
Palonosetron—Headache—Temozolomide—malignant glioma	0.000605	0.00521	CcSEcCtD
Palonosetron—Nausea—Carmustine—malignant glioma	0.000594	0.00511	CcSEcCtD
Palonosetron—Nausea—Temozolomide—malignant glioma	0.000574	0.00494	CcSEcCtD
Palonosetron—CYP2D6—CYP2E1 reactions—CYP2B6—malignant glioma	0.000363	0.0412	CbGpPWpGaD
Palonosetron—CYP2D6—Fatty acids—CYP2B6—malignant glioma	0.000283	0.0321	CbGpPWpGaD
Palonosetron—CYP2D6—Oxidation by Cytochrome P450—POR—malignant glioma	0.000265	0.03	CbGpPWpGaD
Palonosetron—CYP3A4—Liver X Receptor Pathway—CYP2B6—malignant glioma	0.000256	0.029	CbGpPWpGaD
Palonosetron—HTR3A—Ion channel transport—ATP1B2—malignant glioma	0.00025	0.0284	CbGpPWpGaD
Palonosetron—CYP2D6—Xenobiotics—CYP2B6—malignant glioma	0.000225	0.0255	CbGpPWpGaD
Palonosetron—CYP1A2—Oxidation by Cytochrome P450—POR—malignant glioma	0.000224	0.0254	CbGpPWpGaD
Palonosetron—CYP2D6—Xenobiotics—CYP2C18—malignant glioma	0.000195	0.0221	CbGpPWpGaD
Palonosetron—CYP1A2—Xenobiotics—CYP2B6—malignant glioma	0.00019	0.0216	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—RUNX3—malignant glioma	0.000176	0.02	CbGpPWpGaD
Palonosetron—CYP3A4—Oxidation by Cytochrome P450—POR—malignant glioma	0.000173	0.0196	CbGpPWpGaD
Palonosetron—CYP1A2—Xenobiotics—CYP2C18—malignant glioma	0.000165	0.0187	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—MYB—malignant glioma	0.000163	0.0185	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—SOX2—malignant glioma	0.000157	0.0179	CbGpPWpGaD
Palonosetron—CYP3A4—Xenobiotics—CYP2B6—malignant glioma	0.000147	0.0167	CbGpPWpGaD
Palonosetron—CYP1A2—Tryptophan metabolism—ASMT—malignant glioma	0.000137	0.0156	CbGpPWpGaD
Palonosetron—CYP3A4—Xenobiotics—CYP2C18—malignant glioma	0.000127	0.0145	CbGpPWpGaD
Palonosetron—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.000125	0.0141	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—YWHAE—malignant glioma	0.000122	0.0139	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—NTRK2—malignant glioma	0.000122	0.0139	CbGpPWpGaD
Palonosetron—CYP3A4—Irinotecan Pathway—BCHE—malignant glioma	0.000119	0.0136	CbGpPWpGaD
Palonosetron—HTR3A—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000109	0.0123	CbGpPWpGaD
Palonosetron—CYP3A4—Tryptophan metabolism—ASMT—malignant glioma	0.000106	0.012	CbGpPWpGaD
Palonosetron—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2B6—malignant glioma	0.000101	0.0115	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—GJA1—malignant glioma	0.000101	0.0114	CbGpPWpGaD
Palonosetron—HTR3A—Transmembrane transport of small molecules—FTH1—malignant glioma	9.95e-05	0.0113	CbGpPWpGaD
Palonosetron—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	9.61e-05	0.0109	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12A—malignant glioma	9.51e-05	0.0108	CbGpPWpGaD
Palonosetron—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	9.33e-05	0.0106	CbGpPWpGaD
Palonosetron—CYP2D6—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	9.21e-05	0.0105	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—HES1—malignant glioma	8.76e-05	0.00995	CbGpPWpGaD
Palonosetron—HTR3A—Transmembrane transport of small molecules—ATP1B2—malignant glioma	8.69e-05	0.00987	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor—NF1—malignant glioma	8.48e-05	0.00962	CbGpPWpGaD
Palonosetron—CYP1A2—Tryptophan metabolism—CYP2C18—malignant glioma	8.48e-05	0.00962	CbGpPWpGaD
Palonosetron—HTR3A—Transmembrane transport of small molecules—APOD—malignant glioma	8.46e-05	0.0096	CbGpPWpGaD
Palonosetron—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	8.09e-05	0.00918	CbGpPWpGaD
Palonosetron—CYP2D6—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	7.98e-05	0.00906	CbGpPWpGaD
Palonosetron—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	7.9e-05	0.00897	CbGpPWpGaD
Palonosetron—CYP1A2—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	7.8e-05	0.00886	CbGpPWpGaD
Palonosetron—CYP2D6—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	7.56e-05	0.00859	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—HIF1A—malignant glioma	7.34e-05	0.00834	CbGpPWpGaD
Palonosetron—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	6.85e-05	0.00778	CbGpPWpGaD
Palonosetron—CYP1A2—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	6.76e-05	0.00768	CbGpPWpGaD
Palonosetron—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	6.56e-05	0.00745	CbGpPWpGaD
Palonosetron—CYP3A4—Tryptophan metabolism—CYP2C18—malignant glioma	6.54e-05	0.00743	CbGpPWpGaD
Palonosetron—CYP3A4—Irinotecan Pathway—APC—malignant glioma	6.48e-05	0.00736	CbGpPWpGaD
Palonosetron—CYP1A2—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	6.41e-05	0.00727	CbGpPWpGaD
Palonosetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	6.1e-05	0.00693	CbGpPWpGaD
Palonosetron—CYP3A4—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	6.02e-05	0.00683	CbGpPWpGaD
Palonosetron—CYP1A2—Arachidonic acid metabolism—PTGS1—malignant glioma	6.01e-05	0.00682	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—malignant glioma	5.97e-05	0.00678	CbGpPWpGaD
Palonosetron—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	5.56e-05	0.00631	CbGpPWpGaD
Palonosetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	5.29e-05	0.006	CbGpPWpGaD
Palonosetron—CYP1A2—Estrogen Receptor Pathway—STAT3—malignant glioma	5.28e-05	0.00599	CbGpPWpGaD
Palonosetron—CYP3A4—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	5.22e-05	0.00593	CbGpPWpGaD
Palonosetron—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	4.97e-05	0.00564	CbGpPWpGaD
Palonosetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	4.95e-05	0.00561	CbGpPWpGaD
Palonosetron—HTR3A—Ion channel transport—RAF1—malignant glioma	4.93e-05	0.00559	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—CXCL8—malignant glioma	4.76e-05	0.00541	CbGpPWpGaD
Palonosetron—CYP1A2—Tryptophan metabolism—CAT—malignant glioma	4.62e-05	0.00525	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—IL1B—malignant glioma	4.57e-05	0.00519	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—CASP3—malignant glioma	4.56e-05	0.00518	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—malignant glioma	4.39e-05	0.00499	CbGpPWpGaD
Palonosetron—HTR3A—Transmembrane transport of small molecules—TFRC—malignant glioma	4.33e-05	0.00491	CbGpPWpGaD
Palonosetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	4.29e-05	0.00487	CbGpPWpGaD
Palonosetron—CYP1A2—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	4.21e-05	0.00478	CbGpPWpGaD
Palonosetron—CYP1A2—Phase II conjugation—GSTT1—malignant glioma	4.08e-05	0.00463	CbGpPWpGaD
Palonosetron—CYP2D6—Biological oxidations—CYP2B6—malignant glioma	4.02e-05	0.00456	CbGpPWpGaD
Palonosetron—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	3.99e-05	0.00452	CbGpPWpGaD
Palonosetron—HTR3A—Transmembrane transport of small molecules—SLC5A5—malignant glioma	3.98e-05	0.00451	CbGpPWpGaD
Palonosetron—CYP2D6—Metapathway biotransformation—CYP2B6—malignant glioma	3.96e-05	0.0045	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—VEGFA—malignant glioma	3.87e-05	0.00439	CbGpPWpGaD
Palonosetron—HTR3A—Transmembrane transport of small molecules—SLC6A3—malignant glioma	3.78e-05	0.0043	CbGpPWpGaD
Palonosetron—CYP3A4—Tryptophan metabolism—CAT—malignant glioma	3.57e-05	0.00405	CbGpPWpGaD
Palonosetron—CYP2D6—Biological oxidations—CYP2C18—malignant glioma	3.48e-05	0.00395	CbGpPWpGaD
Palonosetron—CYP2D6—Metapathway biotransformation—CYP2C18—malignant glioma	3.44e-05	0.0039	CbGpPWpGaD
Palonosetron—CYP1A2—Biological oxidations—CYP2B6—malignant glioma	3.4e-05	0.00386	CbGpPWpGaD
Palonosetron—CYP1A2—Metapathway biotransformation—CYP2B6—malignant glioma	3.36e-05	0.00381	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—TNF—malignant glioma	3.32e-05	0.00376	CbGpPWpGaD
Palonosetron—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	3.25e-05	0.00369	CbGpPWpGaD
Palonosetron—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	3.08e-05	0.00349	CbGpPWpGaD
Palonosetron—CYP1A2—Biological oxidations—CYP2C18—malignant glioma	2.95e-05	0.00335	CbGpPWpGaD
Palonosetron—CYP1A2—Metapathway biotransformation—CYP2C18—malignant glioma	2.91e-05	0.0033	CbGpPWpGaD
Palonosetron—CYP1A2—Phase II conjugation—GSTP1—malignant glioma	2.83e-05	0.00321	CbGpPWpGaD
Palonosetron—CYP2D6—Biological oxidations—GSTT1—malignant glioma	2.82e-05	0.0032	CbGpPWpGaD
Palonosetron—CYP2D6—Biological oxidations—PTGS1—malignant glioma	2.64e-05	0.003	CbGpPWpGaD
Palonosetron—CYP3A4—Biological oxidations—CYP2B6—malignant glioma	2.63e-05	0.00298	CbGpPWpGaD
Palonosetron—CYP3A4—Metapathway biotransformation—CYP2B6—malignant glioma	2.59e-05	0.00294	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—malignant glioma	2.57e-05	0.00292	CbGpPWpGaD
Palonosetron—CYP1A2—Tryptophan metabolism—MDM2—malignant glioma	2.55e-05	0.0029	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—malignant glioma	2.54e-05	0.00289	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—malignant glioma	2.46e-05	0.00279	CbGpPWpGaD
Palonosetron—CYP1A2—Biological oxidations—GSTT1—malignant glioma	2.39e-05	0.00271	CbGpPWpGaD
Palonosetron—CYP1A2—Arachidonic acid metabolism—PTGS2—malignant glioma	2.3e-05	0.00261	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—malignant glioma	2.29e-05	0.0026	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—malignant glioma	2.28e-05	0.00259	CbGpPWpGaD
Palonosetron—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	2.28e-05	0.00259	CbGpPWpGaD
Palonosetron—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	2.25e-05	0.00255	CbGpPWpGaD
Palonosetron—CYP1A2—Biological oxidations—PTGS1—malignant glioma	2.24e-05	0.00254	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—RTEL1—malignant glioma	1.97e-05	0.00224	CbGpPWpGaD
Palonosetron—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	1.97e-05	0.00224	CbGpPWpGaD
Palonosetron—CYP2D6—Biological oxidations—GSTP1—malignant glioma	1.95e-05	0.00222	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—malignant glioma	1.94e-05	0.0022	CbGpPWpGaD
Palonosetron—CYP2D6—Metapathway biotransformation—GSTP1—malignant glioma	1.93e-05	0.00219	CbGpPWpGaD
Palonosetron—CYP3A4—Biological oxidations—GSTT1—malignant glioma	1.84e-05	0.00209	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor—MYC—malignant glioma	1.78e-05	0.00203	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—malignant glioma	1.75e-05	0.00198	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—malignant glioma	1.75e-05	0.00198	CbGpPWpGaD
Palonosetron—CYP3A4—Biological oxidations—PTGS1—malignant glioma	1.73e-05	0.00196	CbGpPWpGaD
Palonosetron—HTR3A—Transmembrane transport of small molecules—RAF1—malignant glioma	1.71e-05	0.00195	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—RTEL1—malignant glioma	1.67e-05	0.0019	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—malignant glioma	1.66e-05	0.00189	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor—TNF—malignant glioma	1.66e-05	0.00189	CbGpPWpGaD
Palonosetron—CYP1A2—Biological oxidations—GSTP1—malignant glioma	1.65e-05	0.00188	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—malignant glioma	1.65e-05	0.00187	CbGpPWpGaD
Palonosetron—CYP1A2—Metapathway biotransformation—GSTP1—malignant glioma	1.63e-05	0.00185	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—RTEL1—malignant glioma	1.29e-05	0.00147	CbGpPWpGaD
Palonosetron—CYP3A4—Biological oxidations—GSTP1—malignant glioma	1.28e-05	0.00145	CbGpPWpGaD
Palonosetron—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	1.26e-05	0.00143	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	1.2e-05	0.00136	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	1.16e-05	0.00131	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—COX8A—malignant glioma	1.13e-05	0.00129	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—ASMT—malignant glioma	9.64e-06	0.00109	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—COX8A—malignant glioma	9.61e-06	0.00109	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—BCAN—malignant glioma	9.07e-06	0.00103	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	8.59e-06	0.000975	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ASMT—malignant glioma	8.17e-06	0.000927	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	7.98e-06	0.000906	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—BCAN—malignant glioma	7.68e-06	0.000872	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—COX8A—malignant glioma	7.42e-06	0.000842	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—IDH2—malignant glioma	7.31e-06	0.00083	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—CYP2B6—malignant glioma	6.87e-06	0.00078	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ASMT—malignant glioma	6.31e-06	0.000716	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—IDH1—malignant glioma	6.28e-06	0.000713	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—IDH2—malignant glioma	6.19e-06	0.000703	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—SPHK1—malignant glioma	6.08e-06	0.00069	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—CYP2C18—malignant glioma	5.96e-06	0.000676	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—BCAN—malignant glioma	5.93e-06	0.000673	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	5.84e-06	0.000663	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CYP2B6—malignant glioma	5.82e-06	0.000661	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—IDH1—malignant glioma	5.32e-06	0.000604	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—SPHK1—malignant glioma	5.15e-06	0.000585	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CYP2C18—malignant glioma	5.05e-06	0.000573	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—GSTT1—malignant glioma	4.82e-06	0.000547	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—IDH2—malignant glioma	4.78e-06	0.000542	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	4.76e-06	0.00054	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—PTGS1—malignant glioma	4.52e-06	0.000513	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CYP2B6—malignant glioma	4.49e-06	0.00051	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	4.34e-06	0.000492	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—BCHE—malignant glioma	4.2e-06	0.000477	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	4.18e-06	0.000475	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—SLC5A5—malignant glioma	4.15e-06	0.000471	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—IDH1—malignant glioma	4.11e-06	0.000466	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—GSTT1—malignant glioma	4.08e-06	0.000463	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—SPHK1—malignant glioma	3.98e-06	0.000451	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CYP2C18—malignant glioma	3.9e-06	0.000442	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—PTGS1—malignant glioma	3.83e-06	0.000434	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	3.81e-06	0.000433	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—BCHE—malignant glioma	3.56e-06	0.000404	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—SLC5A5—malignant glioma	3.51e-06	0.000399	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—GSTP1—malignant glioma	3.34e-06	0.000379	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	3.32e-06	0.000377	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	3.29e-06	0.000374	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—CAT—malignant glioma	3.25e-06	0.000369	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—GSTT1—malignant glioma	3.15e-06	0.000358	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—NCOR1—malignant glioma	3.07e-06	0.000348	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—PTGS1—malignant glioma	2.95e-06	0.000335	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.87e-06	0.000326	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—GSTP1—malignant glioma	2.83e-06	0.000321	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CAT—malignant glioma	2.75e-06	0.000313	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—BCHE—malignant glioma	2.74e-06	0.000312	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—SLC5A5—malignant glioma	2.71e-06	0.000308	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—NCOR1—malignant glioma	2.6e-06	0.000295	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—CAV1—malignant glioma	2.5e-06	0.000284	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—PIK3CG—malignant glioma	2.28e-06	0.000259	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—PPARG—malignant glioma	2.2e-06	0.00025	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—GSTP1—malignant glioma	2.18e-06	0.000248	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CAT—malignant glioma	2.12e-06	0.000241	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CAV1—malignant glioma	2.12e-06	0.000241	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.03e-06	0.00023	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—NCOR1—malignant glioma	2.01e-06	0.000228	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—PIK3CD—malignant glioma	2e-06	0.000227	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—PIK3CG—malignant glioma	1.93e-06	0.000219	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—PPARG—malignant glioma	1.86e-06	0.000212	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—PIK3CB—malignant glioma	1.75e-06	0.000198	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—PTGS2—malignant glioma	1.73e-06	0.000196	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—PIK3CD—malignant glioma	1.7e-06	0.000193	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CAV1—malignant glioma	1.64e-06	0.000186	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—PTEN—malignant glioma	1.51e-06	0.000171	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—PIK3CG—malignant glioma	1.49e-06	0.000169	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—PIK3CB—malignant glioma	1.48e-06	0.000168	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—PTGS2—malignant glioma	1.47e-06	0.000166	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—PPARG—malignant glioma	1.44e-06	0.000163	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.31e-06	0.000149	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—PTEN—malignant glioma	1.28e-06	0.000145	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.14e-06	0.00013	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—PTGS2—malignant glioma	1.13e-06	0.000128	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—PIK3CA—malignant glioma	1.06e-06	0.000121	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—PTEN—malignant glioma	9.87e-07	0.000112	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—PIK3CA—malignant glioma	9.02e-07	0.000102	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—AKT1—malignant glioma	8.7e-07	9.87e-05	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—AKT1—malignant glioma	7.37e-07	8.36e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—PIK3CA—malignant glioma	6.96e-07	7.9e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—AKT1—malignant glioma	5.69e-07	6.45e-05	CbGpPWpGaD
